Letroz 2.5 mg Tablet
$11.15
$8.38
Letroz 2.5 mg Tablet is an effective medication classified as an aromatase inhibitor, primarily used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. By reducing estrogen levels in the body, Letroz plays a crucial role in slowing or stopping the growth of certain types of breast tumors that require estrogen to thrive. This powerful tablet not only aids in the initial management of breast cancer but also serves as a preventative measure to reduce the risk of cancer recurrence. It is essential to follow your healthcare provider's guidance regarding dosage and administration, as improper use can lead to potential side effects, including bone thinning and increased risk of fractures. Patients should be aware of any pre-existing conditions and inform their doctors about other medications they are taking to avoid interactions. Regular monitoring and follow-up appointments are recommended to ensure optimal results and manage any adverse effects effectively. Letroz 2.5 mg Tablet represents a vital component in the ongoing fight against breast cancer, empowering women with an essential tool for their treatment journey. Always consult with your healthcare professional before starting this medication to ensure it aligns with your specific health needs.
मात्रा
Active Pharmaceutical Ingredient
Uses
• Letroz •5 mg tablet is primarily used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. It works by reducing estrogen levels in the body, which can help slow or stop the growth of certain types of breast tumors that require estrogen to grow. This makes Letroz •5 mg an essential part of therapy for patients diagnosed with this condition. Typically, it is prescribed after surgery or radiation therapy to help prevent cancer recurrence.
• In addition to its role in treating breast cancer, Letroz •5 mg tablet may also be utilized in various clinical settings to manage advanced breast cancer cases. It is particularly effective for patients who have experienced disease progression following other hormonal therapies. By inhibiting aromatase, Letroz •5 mg helps to maintain lower estrogen levels, which is crucial for controlling tumor growth. Healthcare providers often consider this option when evaluating treatment plans for advanced cases.
• Letroz •5 mg tablet can be part of a comprehensive treatment regimen that includes other therapies such as chemotherapy or targeted treatments. Physicians may recommend Letroz •5 mg to enhance the overall effectiveness of cancer management strategies. This combination approach aims to improve patient outcomes and quality of life. Regular monitoring and assessment are essential to ensure the treatment is working effectively.
• The convenience of taking Letroz •5 mg tablet, either with or without food, allows for flexibility in a patient’s daily routine. It is advised to take the tablet at the same time each day to maintain consistent drug levels in the body. This adherence can significantly contribute to the success of the treatment plan. Patients should follow their healthcare provider's instructions to optimize the benefits of Letroz •5 mg tablet.
Benefits
Letroz 2.5 mg Tablet belongs to a class of drugs called aromatase inhibitors. It inhibits the enzyme aromatase, which plays a crucial role in the production of estrogen. By blocking aromatase, Letroz 2.5 mg effectively lowers estrogen levels, which is beneficial in hormone-dependent breast cancers. Letroz 2.5 mg Tablet is primarily used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. It helps to slow down or stop the growth of breast cancer cells by reducing the levels of estrogen in the body. Letroz 2.5 mg Tablet can improve disease-free survival rates in postmenopausal women with hormone receptor-positive breast cancer when compared to other hormonal therapies. Letroz 2.5 mg Tablet is commonly used as adjuvant therapy after surgery or other primary treatments for breast cancer. It helps to reduce the risk of cancer recurrence and improves the chances of long-term remission. Letroz 2.5 mg has also been explored for off-label uses, such as fertility treatment in women with polycystic ovary syndrome (PCOS) who are trying to conceive. In such cases, Letroz 2.5 mg Tablet helps induce ovulation by suppressing estrogen production. It's important to note that while Letroz 2.5 mg Tablet has several benefits, it should only be used under the guidance of a healthcare professional. The appropriate use of Letroz 2.5 mg Tablet depends on individual factors and should be discussed with a qualified medical practitioner.
Side Effects
Like all medication, Letroz 2.5 mg Tablet may cause some side effects. If you experience any of these side effects contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.
Most Common Side Effects
• High Blood Pressure
• Hot Flashes
• Vomiting
• Diarrhoea
• Hair Thinness
• Weight Gain
• Vaginal Dryness
• Appetite Loss
• Skin Dryness
• High Levels of Cholesterol
• Pain in Muscles and Bones
• Swelling
Common Side Effects
• Coughing of Blood
• Fainting
• Liver Inflammation
• Breathlessness
• Vision Changes
• Allergic Reactions
• Fainting
How To Use
Letroz 2.5 mg Tablet can be taken with or without food. Try to take your Letroz 2.5 mg at the same time each day. You can choose a time that suits your everyday routine. This will make it easier to remember to take your medicine. Swallow the tablet whole with a drink of water. Do not crush or chew it. If you forget a dose take it as soon as you remember, unless your next dose is due in 2 or 3 hours. In this case, skip the missed dose and take your next one at the usual time. Do not take a double dose to make up for a forgotten dose.
Safety Advice
• Alcohol: It is not recommended to consume alcohol while taking Letroz 2.5 mg Tablet. Alcohol may increase the risk of side effects or interfere with the effectiveness of the Letroz 2.5 mg. It is best to talk to your doctor or pharmacist before consuming alcohol while taking any medicine.
• Kidney: Letroz 2.5 mg Tablet is safe for use in kidney disease patients. No dosage adjustment is required for kidney patients with creatinine clearance greater than 10 mL/min. Please consult your doctor if you have kidney impairment or any concerns.
• Breastfeeding: It is not recommended to breastfeed while taking Letroz 2.5 mg. Letroz 2.5 mg Tablet may pass into breast milk and harm the infant. If you are breastfeeding and taking Letroz 2.5 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Letroz 2.5 mg Tablet is safe for mild to moderate liver disease patients. No dosage adjustment is required for mild to moderate liver disease patients. In severe liver disease, patients are used with caution. Dose adjustment of Letroz 2.5 mg may be needed. Please consult your doctor.
• Pregnancy: Use of Letroz 2.5 mg Tablet may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Letroz 2.5 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Letroz 2.5 mg Tablet may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Letroz 2.5 mg.